Publications by authors named "Per Johanson"

Claim this Profile
A
A Case Study of Model-Informed Drug Development of a Novel PCSK9 Antisense Oligonucleotide. Part 2: Phase 2 to Phase 3.
Jane Knöchel, Catarina Nilsson, Björn Carlsson, Alexis Hofherr, Per Johanson

CPT Pharmacometrics Syst Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
Marc P Bonaca, KyungAh Im, Giulia Magnani, Sameer Bansilal, Mikael Dellborg, Per Johanson

Eur Heart J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.
David D Berg, Stephen D Wiviott, Benjamin M Scirica, Thomas A Zelniker, Erica L Goodrich, Per Johanson

Diabetes Care· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
Brian A Bergmark, Deepak L Bhatt, P Gabriel Steg, Andrzej Budaj, Robert F Storey, Per Johanson

J Am Heart Assoc· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction.
Giulia Magnani, Diego Ardissino, KyungAh Im, Andrzej Budaj, Robert F Storey, Per Johanson

J Am Heart Assoc· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Nicholas A Marston, Marc P Bonaca, Petr Jarolim, Erica L Goodrich, Deepak L Bhatt, Per Johanson

JAMA Cardiol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF.
Kieran F Docherty, Pardeep S Jhund, Inder Anand, Olof Bengtsson, Michael Böhm, Per Johanson

Circulation· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58.
Marc P Bonaca, Stephen D Wiviott, Thomas A Zelniker, Ofri Mosenzon, Deepak L Bhatt, Per Johanson

Circulation· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
Remo H M Furtado, Jose C Nicolau, Giulia Magnani, Kyungah Im, Deepak L Bhatt, Per Johanson

Eur Heart J· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Baris Gencer, Xinmin S Li, Yared Gurmu, Marc P Bonaca, David A Morrow, Per Johanson

J Am Heart Assoc· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Remo H M Furtado, Ramkumar V Venkateswaran, Jose C Nicolau, Yared Gurmu, Deepak L Bhatt, Per Johanson

J Am Heart Assoc· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Mark C Petrie, Subodh Verma, Kieran F Docherty, Silvio E Inzucchi, Inder Anand, Per Johanson

JAMA· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.
David D Berg, Stephen D Wiviott, Benjamin M Scirica, Yared Gurmu, Ofri Mosenzon, Per Johanson

Circulation· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.
Mikael Dellborg, Marc P Bonaca, Robert F Storey, P Gabriel Steg, Kyung A Im, Per Johanson

Eur Heart J Cardiovasc Pharmacother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor.
Mohammad Niazi, Jenny Wissmar, Anders R Berggren, Christer Karlsson, Per Johanson

Clin Drug Investig· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased admissions and hospital costs with a neutral effect on mortality following lowering of the troponin T cutoff point to the 99th percentile.
Christian Bjurman, Matteus Zywczyk, Bertil Lindahl, Tobias Carlsson, Per Johanson

Cardiol J· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
Eri T Kato, Michael G Silverman, Ofri Mosenzon, Thomas A Zelniker, Avivit Cahn, Per Johanson

Circulation· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
Marc P Bonaca, Stephen D Wiviott, David A Morrow, P Gabriel Steg, Christian Hamm, Per Johanson

J Am Heart Assoc· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54.
Marc P Bonaca, Robert F Storey, Pierre Theroux, P Gabriel Steg, Deepak L Bhatt, Per Johanson

J Am Coll Cardiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive strategies and outcomes for non-ST-segment elevation acute coronary syndromes: a twelve-year experience from SWEDEHEART.
Peter Damman, Tomas Jernberg, Bertil Lindahl, Robbert J de Winter, Anders Jeppsson, Per Johanson

EuroIntervention· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
Gorav Batra, Bodil Svennblad, Claes Held, Tomas Jernberg, Per Johanson

Heart· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehospital ECG signs of acute coronary occlusion are associated with reduced one-year mortality.
Annica Ravn-Fischer, Thomas Karlsson, Per Johanson, Johan Herlitz

Int J Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality.
Christian Bjurman, Mårten Larsson, Per Johanson, Max Petzold, Bertil Lindahl

J Am Coll Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Maarten L Simoons, Bernard R Chaitman, Per Johanson

Circulation· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third universal definition of myocardial infarction.
Kristian Thygesen, Joseph S Alpert, Allan S Jaffe, Maarten L Simoons, Bernard R Chaitman, Per Johanson

J Am Coll Cardiol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis